Teva's 5,800,808 patent, which is not in the Orange Book but was included in the patent litigation, expires on 9/1/15, so a ruling by the Appellate Court in late 2013 is quite relevant.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”